Revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Elevance Health, Inc. (ELV)
Price$396.09Cached quote
Net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $199.13B | $177.01B | $171.34B | $156.59B | $138.64B | $121.87B | $104.21B | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | $71.02B | $61.50B | $60.71B | $58.70B | $64.94B | $61.25B | $61.17B |
| Gross profit | $177.95B | $157.26B | $154.05B | $143.56B | $127.74B | $112.91B | $102.22B | $92.11B | $90.04B | — | — | — | — | $61.36B | $60.71B | $58.70B | $64.52B | $60.78B | $60.74B |
| Gross margin | 89.36% | 88.84% | 89.91% | 91.68% | 92.14% | 92.65% | 98.09% | 100.00% | 100.00% | — | — | — | — | 99.78% | 100.00% | 100.00% | 99.35% | 99.24% | 99.29% |
| Operating expenses | $170.75B | $149.40B | $145.55B | $135.28B | $120.19B | $106.55B | $96.22B | $86.68B | $85.86B | — | — | — | — | $57.74B | $56.93B | $54.62B | $60.34B | $56.43B | — |
| Operating income | $7.20B | $7.86B | $8.50B | $8.28B | $7.56B | $6.36B | $6.00B | $5.43B | $4.17B | $4.80B | $4.75B | $4.42B | $4.00B | $3.62B | $3.78B | $4.08B | $4.18B | $4.35B | — |
| Operating margin | 3.62% | 4.44% | 4.96% | 5.29% | 5.45% | 5.22% | 5.76% | 5.89% | 4.64% | 5.66% | 6.00% | 5.98% | 5.63% | 5.89% | 6.23% | 6.95% | 6.44% | 7.10% | — |
| EBITDA | $8.74B | $9.26B | $10.24B | $9.96B | $8.86B | $7.51B | $7.13B | $6.56B | $4.46B | $5.10B | $5.09B | $4.75B | $4.35B | $3.96B | $4.12B | $4.42B | $4.55B | $4.74B | — |
| EBITDA margin | 4.39% | 5.23% | 5.98% | 6.36% | 6.39% | 6.17% | 6.84% | 7.12% | 4.95% | 6.01% | 6.43% | 6.42% | 6.13% | 6.44% | 6.78% | 7.53% | 7.01% | 7.74% | — |
| Net income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | $2.49B | $2.66B | $2.65B | $2.89B | $4.75B | $2.49B | $3.35B |
| Net profit margin | 2.84% | 3.38% | 3.49% | 3.76% | 4.44% | 3.75% | 4.61% | 4.07% | 4.27% | 2.91% | 3.23% | 3.48% | 3.51% | 4.32% | 4.36% | 4.92% | 7.31% | 4.07% | 5.47% |
| Basic EPSper basic share | $25.28 | $25.81 | $25.38 | $24.56 | $25.26 | $18.23 | $18.81 | $14.53 | $14.70 | $9.39 | $9.73 | $9.31 | $8.34 | $8.26 | $7.35 | $7.03 | $9.96 | $4.79 | $5.64 |
| Diluted EPSper diluted share | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 | $17.98 | $18.47 | $14.19 | $14.35 | $9.21 | $9.38 | $8.99 | $8.20 | $8.18 | $7.25 | $6.94 | $9.88 | $4.76 | $5.56 |
Owners
Reported shareholders
8.76%of listed shares
BlackRock, Inc.18.99M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 8.76%18.99M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 6.48%14.06M shares |
STATE STREET CORP | 4.81%10.43M shares |
WELLINGTON MANAGEMENT GROUP LLP | 4.25%9.21M shares |
First Eagle Investment Management, LLC | 3.86%8.38M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 2.87%6.21M shares |
Sanders Capital, LLC | 2.69%5.83M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.38%5.17M shares |
HARRIS ASSOCIATES L P | 2.27%4.92M shares |
Artisan Partners Limited Partnership | 2.11%4.58M shares |
Invesco Ltd. | 1.95%4.23M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 1.85%4.01M shares |
NORGES BANK | 1.83%3.96M shares |
Bank of New York Mellon Corp | 1.49%3.22M shares |
FMR LLC | 1.44%3.13M shares |
MORGAN STANLEY | 1.20%2.61M shares |
NORTHERN TRUST CORP | 0.98%2.11M shares |
CITIGROUP INC | 0.97%2.1M shares |
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.95%2.07M shares |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 0.93%2.02M shares |
Percentages use 216.84M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2026Form 4 | Penczek Ronald WCAO & Controller | SellCommon Stock | 369 | $403.16 | $148.8K | 3.7K |
| Jun 11, 2026Form 4 | Dixon Robert L JRDirector | SellCommon Stock | 151 | $401.77 | $60.7K | 10.7K |
| May 19, 2026Form 4 | Penczek Ronald WCAO & Controller | SellCommon Stock | 1.5K | $403.13 | $617.2K | 4.1K |
| Mar 12, 2026Form 4 | SCHULMAN AMY WDirector | SellCommon Stock | 26 | $287.50 | $7.5K | 218 |
| Mar 6, 2026Form 4 | Kendrick Charles Morgan JREVP & President, Commercial | SellCommon Stock | 3.2K | $284.92 | $910.6K | 11.8K |